The use of oral BCG in the treatment of metastatic malignant melanoma
- 1 January 1976
- journal article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 2 (2) , 173-181
- https://doi.org/10.1002/mpo.2950020207
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cellular Immune Competence of Breast Cancer Patients Receiving RadiotherapyArchives of Surgery, 1973
- Cell-Mediated Immunity to Human TumorsArchives of Surgery, 1973
- BCG Immunotherapy of Pulmonary Growths from Intravenously Transferred Rat Tumour CellsBritish Journal of Cancer, 1973
- Immunotherapy of cancer. Present Status and Future PotentialCancer, 1972
- Response of Peripheral Blood Lymphocytes from Patients with Diabetes Mellitus to Phytohemagglutinin and Candida Albicans AntigenDiabetes, 1972
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- LEUKÆMIA AND B.C.G.: A Controlled TrialThe Lancet, 1971
- B.C.G. AND LEUKÆMIAThe Lancet, 1971
- B.C.G. VACCINATION AND LEUKÆMIA MORTALITYThe Lancet, 1970
- Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the MouseNature, 1959